Atrial fibrillation: trials for referral

Where the open trials are

Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.

Registry facts, one per line, newest first.

• 6 Nov 2026

  Status changed: Running, not recruiting → Completed

  The CT-verified Data Collection Study to Investigate the Correlation Between the Leadless Pacemaker Tip Location and Echo, ECG

  NCT06910059 · No phase · China

  Source: ClinicalTrials.gov
• 6 Nov 2026

  New in the registry

  From Skull Base to Atrial Fibrillation: Reduced Jugular Foramen Volume as a Structural Correlate of Atrial Fibrillation

  NCT07922655 · No phase · Türkiye

  Source: ClinicalTrials.gov
• 5 Nov 2026

  New in the registry

  Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG

  NCT07918781 · No phase · China

  Source: ClinicalTrials.gov
• 28 Aug 2026

  Phase changed: Phase 2/3 → Phase 2

  Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation

  NCT07792239 · Phase 2 · Poland

  Source: ClinicalTrials.gov
• 5 Nov 2026

  Opened for recruitment

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411 · Phase 3 · Austria, Belgium, Bulgaria, Canada, Czechia, Germany

  Source: ClinicalTrials.gov
• 14 Oct 2026

  Opened for recruitment

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956 · Phase 3 · Bulgaria, Canada, Germany, Spain, Hungary, Italy

  Source: ClinicalTrials.gov
• 10 Aug 2026

  Opened for recruitment

  Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

  NCT07275697 · Phase 4 · Sweden

  Source: ClinicalTrials.gov
• 23 Sept 2025

  Phase changed: Phase 4 → Phase 3

  RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care

  NCT07187570 · Phase 3 · Sweden

  Source: ClinicalTrials.gov
• 2 Dec 2024

  Status changed: Recruiting → Not yet recruiting

  Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation

  NCT06645249 · Phase 4 · Spain

  Source: ClinicalTrials.gov
• 9 Aug 2024

  Status changed: Recruiting → Not yet recruiting

  Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)

  NCT06045858 · Phase 3 · France

  Source: ClinicalTrials.gov
• 6 Jan 2025

  Opened for recruitment

  The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk

  NCT05943821 · Phase 3 · Poland

  Source: ClinicalTrials.gov
• 11 Jul 2023

  Status changed: Recruiting → Not yet recruiting

  First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation

  NCT05939076 · Phase 3 · Bulgaria, Germany, Denmark, United Kingdom, Hungary, Norway

  Source: ClinicalTrials.gov
• 28 May 2025

  Opened for recruitment

  Colchicine After Electrocardioversion for Atrial Fibrillation

  NCT05890664 · Phase 3 · Switzerland, Germany

  Source: ClinicalTrials.gov
• 13 Jun 2025

  Opened for recruitment

  Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia

  NCT05549752 · Phase 3 · Greece

  Source: ClinicalTrials.gov
• 18 May 2026

  Phase changed: Phase 4 → Phase 3

  Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

  NCT05293080 · Phase 3 · Germany, Spain, Netherlands

  Source: ClinicalTrials.gov
• 16 Jun 2026

  Opened for recruitment

  Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

  NCT04695106 · Phase 4 · Poland

  Source: ClinicalTrials.gov
• 16 Jun 2026

  Phase changed: Phase 3 → Phase 4

  Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

  NCT04695106 · Phase 4 · Poland

  Source: ClinicalTrials.gov
• 26 Jun 2026

  Phase changed: Phase 4 → Phase 3

  Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  NCT04045665 · Phase 3 · Brazil, Canada, Germany, United Kingdom, United States

  Source: ClinicalTrials.gov
• 11 Jul 2023

  Opened for recruitment

  Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure

  NCT03445949 · Phase 4 · Poland

  Source: ClinicalTrials.gov
• 27 Mar 2026

  Closed for recruitment

  Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

  NCT03568890 · Phase 4 · Canada, Spain

  Source: ClinicalTrials.gov

New reviews, guidelines and randomised trials in PubMed

• 7 Nov 2026

  Systematic review

  Association Between Colchicine Use and Clinical Outcomes Post Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.

  American journal of cardiovascular drugs : drugs, devices, and other interventions · PubMed

• 7 Nov 2026

  Systematic review

  Efficacy and safety of conscious/deep sedation versus general anesthesia in pulsed field ablation for atrial fibrillation: a systematic review and meta-analysis.

  Frontiers in cardiovascular medicine · PubMed

• 5 Nov 2026

  Meta-analysis

  Natriuretic Peptides as Adjunctive Biomarkers for the Detection of Paroxysmal Atrial Fibrillation in Patients With Cryptogenic Stroke: Systematic Review and Meta-Analysis.

  Clinical cardiology · PubMed

• 4 Nov 2026

  Randomised trial

  A randomized comparison of comprehensive weight loss intervention vs. usual care on recurrences of atrial fibrillation in obese patients after catheter ablation: HOBIT-AF trial.

  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · PubMed

Results card

Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.

• No phaseEnded 29 Oct 2026

  Completed600 participants

  NCT04033510

  Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)

  Registry record

• No phaseEnded 23 Oct 2026

  Completed290 participants

  NCT07490808

  Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation

  Registry record

• No phaseEnded 22 Oct 2026

  Completed518 participants

  NCT05922917

  Pulsed-field Ablation in Patients With Persistent Atrial Fibrillation

  Registry record

• No phaseEnded 17 Oct 2026

  Completed30 participants

  NCT05988424

  Randomised Comparison of the Octaray and Pentaray Catheters

  Registry record

• No phaseEnded 13 Oct 2026

  Completed70 participants

  NCT06358391

  To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access.

  Registry record

• No phaseEnded 5 Oct 2026

  Completed325 participants

  NCT07902739

  Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE

  Registry record

• No phaseEnded Sept 2026

  Withdrawn before start0 participants

  NCT05993104

  Shape vs Substrate in AF

  Reason given: Funder no longer operating so the study team is unable to deliver the study.

  Registry record

• No phaseEnded 25 Sept 2026

  Completed8265 participants

  NCT07874555

  A Real World Evidence Retrospective Data Collection Study of Edoxaban and Rivaroxaban

  Registry record

• No phaseEnded 18 Sept 2026

  Completed142 participants

  NCT05227053

  STOP AF First Post-Approval Study

  Registry record

• No phaseEnded 15 Sept 2026

  Stopped early15 participants

  NCT05653583

  Peripheral Nerve Stimulation Therapy for Atrial Fibrillation

  Reason given: The Sponsor and Principal Investigator have mutually agreed to initiate study closure due to prolonged recruitment challenges that have prevented the trial from meeting its enrollment milestones within the projected study timeline.

  Registry record

• No phaseEnded 8 Sept 2026

  Completed67 participants

  NCT06580275

  The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

  Registry record

• No phaseEnded 3 Sept 2026

  Completed41 participants

  NCT06910059

  The CT-verified Data Collection Study to Investigate the Correlation Between the Leadless Pacemaker Tip Location and Echo, ECG

  Registry record

• No phaseEnded 1 Sept 2026

  Completed240 participants

  NCT07922655

  From Skull Base to Atrial Fibrillation: Reduced Jugular Foramen Volume as a Structural Correlate of Atrial Fibrillation

  Registry record

• Phase 1Ended Aug 2026

  Withdrawn before start0 participants

  NCT05223725

  Gene Therapy for Post-Operative Atrial Fibrillation

  Reason given: Problems with receiving investigational agent and problems with funding

  Registry record

• No phaseEnded 31 Aug 2026

  Completed515 participants

  NCT05855538

  Clinical Cohorts for Validation of New Digital Biomarkers

  Registry record

• No phaseEnded Aug 2026

  Withdrawn before start0 participants

  NCT06155357

  A Study of a Lifestyle Program on Recurrent Atrial Fibrillation

  Reason given: Lack of funding

  Registry record

• No phaseEnded 31 Jul 2026

  Completed60 participants

  NCT07271615

  Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting

  Registry record

• No phaseEnded 27 Jul 2026

  Completed33 participants

  NCT07812935

  Closed-Loop Stimulation in Left Bundle Branch Area Pacing

  Registry record

• Phase 4Ended 22 Jul 2026

  Completed948 participants

  NCT03950076

  EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

  Registry record

• No phaseEnded 8 Jul 2026

  Stopped early338 participants

  NCT04624646

  Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

  Reason given: Enrollment was closed early in July 2025 because of slow recruitment (338 of 600 planned participants; 324 were required for the superiority comparison). The 12-month follow-up period for all randomized participants ended in July 2026.

  Registry record

Not medical advice. fetched 9 Nov 2026